Eiger BioPharmaceuticals, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Assets for the quarter ending December 31, 2023 was -113 %, a 69.1% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2023 was -113 %, a 69.1% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2022 was -66.6 %, a 194% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2021 was -22.7 %, a 58.6% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -113 -46.1 -69.1% Jan 1, 2023 Dec 31, 2023
2022 -66.6 -44 -194% Jan 1, 2022 Dec 31, 2022
2021 -22.7 +32 +58.6% Jan 1, 2021 Dec 31, 2021
2020 -54.7 +7.6 +12.2% Jan 1, 2020 Dec 31, 2020
2019 -62.3 +12.7 +17% Jan 1, 2019 Dec 31, 2019
2018 -75 +26.4 +26.1% Jan 1, 2018 Dec 31, 2018
2017 -101 -18.4 -22.1% Jan 1, 2017 Dec 31, 2017
2016 -83 -52.9 -176% Jan 1, 2016 Dec 31, 2016
2015 -30.1 -27.2 -936% Jan 1, 2015 Dec 31, 2015
2014 -2.91 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.